Oropharynx Cancer
Oncology·MeSH: Anus Neoplasms
Prevalence
4.4 / 100K
Incidence
2.5 / 100K/yr
1 drug in development·1 company·6 clinical trials
Drug Pipeline by Phase
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| hb-201 iv | HOOKIPA Pharma Inc. (HOOK) |
Frequently asked questions
How many drugs are in development for Oropharynx Cancer?
BioSniper tracks 1 drug in development for Oropharynx Cancer across 1 company.
How many clinical trials target Oropharynx Cancer?
There are 6 clinical trials targeting Oropharynx Cancer tracked by BioSniper.
What is the prevalence of Oropharynx Cancer?
The estimated prevalence of Oropharynx Cancer is approximately 4.4 per 100,000 population.
Deep-dive into Oropharynx Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis